PPI Medications and Seniors — The Hidden Risks of Long-Term Acid Reflux Drugs

Somewhere in your parent's medicine cabinet, there is probably a small capsule they take every morning for acid reflux. It might be omeprazole, lansoprazole, pantoprazole, or esomeprazole — all members of a drug class called proton pump inhibitors, or PPIs. Your parent may have been taking one for years. Their doctor prescribed it once, it worked, and nobody ever revisited the decision.

This is remarkably common. PPIs are among the most prescribed medications in the United States, and seniors are the heaviest users. They are also among the most over-prescribed — studies suggest that between 25 and 70 percent of PPI prescriptions lack a clear ongoing indication. For elderly patients, that overuse carries real and underappreciated consequences.

What PPIs do and why they are so widely used

Proton pump inhibitors reduce stomach acid production by blocking the enzyme system in the stomach's parietal cells. They are highly effective at treating conditions caused by excess acid: gastroesophageal reflux disease (GERD), peptic ulcers, Barrett's esophagus, and a condition called Zollinger-Ellison syndrome. They are also used short-term to protect the stomach lining in patients taking NSAIDs or corticosteroids.

The problem is not that PPIs do not work. They work extremely well — and that success is part of the problem. Symptoms disappear quickly, so both doctors and patients are reluctant to stop. Many elderly patients were started on a PPI during a hospital stay for stress ulcer prevention, discharged with the prescription still active, and never taken off it. Others started taking over-the-counter omeprazole for occasional heartburn and never stopped.

The labels on over-the-counter PPIs recommend a maximum of 14 days of use, with no more than three 14-day courses per year. In practice, millions of people take them daily for years or even decades.

Why long-term PPI use is concerning in elderly patients

Stomach acid serves important biological functions beyond digestion. It helps the body absorb critical nutrients, protects against bacterial infections in the gut, and supports bone metabolism. Suppressing acid production for extended periods disrupts all of these processes — and the consequences accumulate over time, particularly in elderly patients who are already vulnerable.

Bone fractures

Multiple large studies have found an association between long-term PPI use and increased risk of hip, spine, and wrist fractures. The mechanism appears related to impaired calcium absorption — without adequate stomach acid, the body cannot absorb calcium efficiently from food. For elderly patients already at risk of osteoporosis, this adds a meaningful layer of fracture risk.

The FDA issued a safety communication about this risk in 2010, and updated PPI labels now include fracture warnings for high-dose or long-duration use. Yet the prescribing behavior has been slow to change.

Kidney damage

Chronic PPI use has been linked to increased rates of chronic kidney disease, acute kidney injury, and accelerated progression of existing kidney problems. A 2016 study following over 10,000 patients found that PPI users had a 20 to 50 percent higher risk of chronic kidney disease compared to non-users. For elderly patients whose kidney function is already declining with age, this additional burden is particularly concerning.

The damage can be insidious. PPI-related kidney injury often develops gradually without obvious symptoms, making it easy to miss until significant function has been lost.

Nutrient deficiencies

Beyond calcium, long-term acid suppression impairs absorption of magnesium, iron, and vitamin B12. Magnesium deficiency can cause muscle cramps, irregular heartbeat, and seizures. B12 deficiency contributes to fatigue, cognitive impairment, and neuropathy — symptoms that are easily attributed to "normal aging" rather than recognized as a medication side effect.

In elderly patients who may already have marginal nutrient levels due to reduced dietary intake, these deficiencies compound more quickly and with more serious consequences.

Increased infection risk

Stomach acid is a front-line defense against bacteria entering through the mouth. Suppressing acid production creates a more hospitable environment for pathogens. Long-term PPI use has been associated with increased risk of Clostridioides difficile (C. diff) infection — a dangerous and sometimes fatal intestinal infection that disproportionately affects older adults, especially those in hospitals or nursing facilities.

PPI use has also been linked to higher rates of pneumonia, likely because reduced acid allows bacteria to colonize the upper digestive tract and be aspirated into the lungs.

Cognitive effects

Some research has suggested a link between long-term PPI use and increased dementia risk, though the evidence is mixed and causation has not been established. The proposed mechanisms include B12 deficiency-related cognitive decline and direct effects on brain enzymes. While the jury is still out, the possibility is worth noting for elderly patients already at risk of cognitive decline.

How to talk to your parent's doctor about PPIs

If your parent has been taking a PPI for more than eight weeks without a recent reassessment, it is reasonable to bring this up at their next appointment. Here is how to approach the conversation productively:

Ask why the PPI was originally prescribed

Understanding the original reason matters. If your parent has Barrett's esophagus or a history of bleeding ulcers, continued PPI use may be medically justified despite the risks. If the original reason was "heartburn" or "stomach protection during a hospital stay," there may be no current indication for ongoing use.

Ask whether a trial discontinuation is appropriate

For many patients, the PPI can be safely tapered and discontinued. The standard approach is a gradual step-down: reducing the dose for two to four weeks, then switching to every-other-day dosing, then stopping. Abrupt discontinuation can cause rebound acid hypersecretion — a temporary surge in acid production that feels worse than the original symptoms and leads many patients to restart the drug unnecessarily.

Ask about alternatives

For mild or intermittent symptoms, less aggressive options may be sufficient:

• H2 blockers (famotidine, for example) reduce acid production through a different mechanism with a better long-term safety profile. They are less potent than PPIs but adequate for many patients.
• Antacids (calcium carbonate, magnesium hydroxide) neutralize existing acid without affecting production. They are appropriate for occasional symptoms.
• Lifestyle modifications — elevating the head of the bed, avoiding late meals, reducing dietary triggers — can be surprisingly effective for GERD management when consistently applied.

Ask about monitoring

If your parent does need to continue a PPI long-term, ask about monitoring for known complications. This might include periodic checks of kidney function, magnesium and B12 levels, and bone density screening.

What caregivers can do right now

Review the medication list. Check whether your parent is taking a PPI. Common brand names include Prilosec (omeprazole), Prevacid (lansoprazole), Nexium (esomeprazole), Protonix (pantoprazole), and Aciphex (rabeprazole). Generic versions are often labeled simply by the drug name.

Check the duration. How long have they been taking it? If no one can remember when it started, that itself is a red flag. PPIs prescribed "temporarily" during a hospitalization or procedure have a way of becoming permanent fixtures.

Look for symptoms of complications. Muscle cramps or twitching (magnesium deficiency), fatigue and memory issues (B12 deficiency), bone pain or recent fractures, and recurrent infections can all be PPI-related.

Don't stop it yourself. This is important. Do not take your parent off a PPI without medical supervision. Rebound acid production can be severe and may mask the need for a proper diagnostic workup. The discontinuation needs to be planned and gradual.

Flag it at the next appointment. Bring the question to your parent's doctor. Frame it as a question, not a demand: "My parent has been on omeprazole for several years. Given the recent research about long-term PPI risks in elderly patients, is it worth considering whether they still need it?"

Keeping track of what matters

PPIs are a perfect example of why active medication management matters for elderly parents. A drug that was prescribed for a valid reason five years ago may no longer be appropriate. A side effect that develops gradually may be attributed to aging rather than the medication causing it. Without someone paying attention to the full picture — reviewing each medication, questioning ongoing necessity, and watching for complications — these issues accumulate silently.

If you are managing medications for an aging parent and want a structured way to track every drug, flag medications for review, and prepare for productive doctor conversations, the Medication Management Kit includes templates and checklists designed for exactly this kind of ongoing oversight. It helps you move from reactive problem-solving to proactive medication management.